# LXRX (Lexicon Pharmaceuticals, Inc.) - SEC EDGAR Financial Statements

> Lexicon Pharmaceuticals, Inc. reported $38.54M in revenue and a net loss of $62.35M for the trailing twelve months ended September 30, 2026 (down 20.7% year over year), with a 98.9% gross margin and a -147.4% operating margin.

- Canonical: https://convexityos.com/fundamentals/LXRX
- Markdown: https://convexityos.com/fundamentals/LXRX.md
- SEC CIK: 0001062822
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:32 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001062822&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $38.54M | -20.7% YoY |
| Operating Income | TTM | -$56.81M | -147.4% margin |
| Net Income | TTM | -$62.35M | -161.8% net margin |
| Diluted EPS | TTM | -$0.14 | Split-adjusted |
| Free Cash Flow | TTM | -$67.85M | -176.1% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $183.2M | Total debt: $59.54M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $49.80M | $31.08M | $1.20M | $139K | $298K | $24.00M | $322.1M | $63.21M | $91.69M | $79.26M |
| Cost of Revenue | $274K | $616K | $85K | $0 | $0 | $1.93M | $3.23M | $2.49M | $1.90M | $0 |
| **Gross Profit** | $49.53M | $30.46M | $1.12M | $139K | $298K | $22.07M | $318.8M | $60.72M | $89.79M | $79.26M |
| Research & Development | $61.12M | $84.48M | $58.89M | $52.82M | $55.05M | $153.6M | $91.92M | $100.2M | $152.2M | $164.0M |
| Selling, General & Admin | $37.32M | $143.1M | $114.0M | $48.08M | $32.34M | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | -- | -- | $100.9M | $87.39M | $204.4M | $180.6M | $166.5M | $222.3M | $206.4M |
| **Operating Income** | -$48.91M | -$197.1M | -$171.8M | -$100.8M | -$87.09M | -$47.80M | $141.4M | -$103.3M | -$130.6M | -$127.2M |
| **EBITDA** | -$48.29M | -$196.6M | -$171.2M | -$100.3M | -$86.80M | -$44.87M | $145.1M | -$99.60M | -$127.2M | -$125.1M |
| Interest Expense | -- | -- | -- | $2.78M | $802K | $14.54M | $20.68M | $20.78M | $6.98M | $6.57M |
| Income Before Tax | -- | -- | -- | -- | -$87.76M | -$58.57M | $124.1M | -$120.5M | -$135.7M | -$131.4M |
| Income Tax Expense | -- | $0 | $0 | $0 | $0 | -- | -- | -- | -- | $0 |
| **Net Income** | -$50.34M | -$200.4M | -$177.1M | -$101.9M | -$87.76M | -$58.57M | $130.1M | -$120.5M | -$123.0M | -$131.4M |
| Basic EPS | -$0.14 | -$0.63 | -$0.80 | -$0.62 | -$0.60 | -$0.53 | $1.23 | -$1.14 | -$1.17 | -$1.27 |
| **Diluted EPS** | -$0.14 | -$0.63 | -$0.80 | -$0.62 | -$0.60 | -$0.53 | $1.16 | -$1.14 | -$1.17 | -$1.27 |
| Basic Shares Outstanding | 363.1M | 320.0M | 221.1M | 165.7M | 145.7M | -- | -- | 105.8M | 105.2M | 103.9M |
| Diluted Shares Outstanding | 363.1M | 320.0M | 221.1M | 165.7M | 145.7M | 110.8M | 116.7M | 105.8M | 105.2M | 103.9M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $11.25M | $692K | $21.10M | $5.49M | $14.18M | $28.87M | $1.26M | $26.55M |
| Cost of Revenue | $79K | $39K | $108K | $201K | $10K | $33K | $30K | $348K |
| **Gross Profit** | $11.17M | $653K | $20.99M | $5.29M | $14.17M | $28.83M | $1.23M | $26.21M |
| Research & Development | $16.20M | $17.44M | $12.76M | $11.31M | $18.76M | $15.75M | $15.30M | $26.68M |
| Selling, General & Admin | $9.46M | $9.75M | $9.23M | $8.76M | $7.60M | $9.35M | $11.61M | $32.26M |
| **Operating Income** | -$14.49M | -$26.54M | -$996K | -$14.78M | -$12.19M | $3.74M | -$25.68M | -$32.74M |
| **EBITDA** | -$14.40M | -$26.44M | -$886K | -$14.66M | -$12.04M | $3.91M | -$25.50M | -$32.61M |
| **Net Income** | -$14.01M | -$31.77M | -$1.04M | -$15.53M | -$12.77M | $3.25M | -$25.30M | -$33.77M |
| Basic EPS | -$0.03 | -$0.07 | $0.00 | -- | -$0.04 | $0.01 | -$0.07 | -- |
| **Diluted EPS** | -$0.03 | -$0.07 | $0.00 | -- | -$0.04 | $0.01 | -$0.07 | -- |
| Basic Shares Outstanding | 445.0M | 437.7M | 400.2M | -- | 363.4M | 363.3M | 362.1M | -- |
| Diluted Shares Outstanding | 445.0M | 437.7M | 400.2M | -- | 363.4M | 363.6M | 362.1M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $34.33M | $66.66M | $22.46M | $46.34M | $64.06M | $126.3M | $36.11M | $80.39M | $61.66M | $46.60M |
| Short-Term Investments | $61.90M | $171.3M | $147.6M | $92.01M | $22.68M | $26.01M | $235.5M | $79.67M | $249.1M | $299.9M |
| **Cash & Short-Term Investments** | $96.23M | $238.0M | $170.0M | $138.4M | $86.74M | $152.3M | $271.7M | $160.1M | $310.8M | $346.5M |
| Accounts Receivable, Net | $2.38M | $3.47M | $1.01M | $28K | $14K | $395K | $56.53M | $5.92M | $4.83M | $7.49M |
| Inventory | $281K | $231K | $381K | $0 | -- | $0 | $4.24M | $4.68M | $1.95M | $0 |
| Other Current Assets | $3.00M | $4.53M | $5.13M | $2.48M | $2.16M | $5.05M | $5.32M | $2.67M | $4.43M | $3.88M |
| **Total Current Assets** | $101.9M | $246.2M | $176.5M | $140.9M | $88.92M | $157.7M | $337.8M | $173.3M | $322.0M | $357.9M |
| Property, Plant & Equipment, Net | $1.86M | $2.48M | $1.99M | $2.07M | $1.18M | $295K | $14.05M | $15.87M | $17.69M | $19.39M |
| Goodwill | $44.54M | $44.54M | $44.54M | $44.54M | $44.54M | $44.54M | $44.54M | $44.54M | $44.54M | $44.54M |
| Intangible Assets | -- | -- | -- | -- | -- | -- | $19.72M | $50.12M | $51.88M | $53.36M |
| Other Non-Current Assets | $368K | $368K | $828K | $412K | $2.27M | $1.23M | $1.66M | $285K | $429K | $461K |
| **Total Non-Current Assets** | $83.09M | $52.23M | $52.88M | $53.43M | $47.99M | $46.07M | $79.96M | $110.8M | $114.5M | $117.8M |
| **Total Assets** | $185.0M | $298.4M | $229.4M | $194.3M | $136.9M | $203.8M | $417.7M | $284.1M | $436.5M | $475.6M |
| Accounts Payable | $3.08M | $14.80M | $14.39M | $10.39M | $9.15M | $5.47M | $12.18M | $12.05M | $38.76M | $52.88M |
| Short-Term Debt | $4.59M | $0 | -- | -- | $0 | $11.65M | $11.01M | $1.11M | $14.09M | $16.28M |
| Deferred Revenue (Current) | -- | $0 | -- | -- | -- | -- | $0 | $2.34M | $40.35M | $63.37M |
| **Total Current Liabilities** | $20.87M | $45.25M | $31.55M | $23.17M | $22.12M | $46.81M | $65.34M | $36.75M | $105.5M | $164.6M |
| Long-Term Debt | $49.41M | $100.3M | $99.51M | $48.58M | $0 | $0 | $234.2M | $243.9M | $231.6M | $85.17M |
| Deferred Revenue (Non-Current) | -- | -- | -- | -- | -- | -- | $0 | $23.65M | $24.90M | $48.93M |
| Other Non-Current Liabilities | $7.17M | $6.92M | $5.26M | $5.42M | $1.19M | $611K | $1.10M | $238K | $292K | $805K |
| **Total Non-Current Liabilities** | $56.58M | $107.2M | $104.8M | $54.00M | $1.19M | $611K | $235.3M | $273.8M | $262.8M | $153.6M |
| **Total Liabilities** | $77.45M | $152.5M | $136.3M | $77.17M | $23.31M | $47.42M | $300.6M | $310.5M | $368.3M | $318.2M |
| **Total Debt (incl. Leases)** | $62.24M | $106.1M | $106.1M | $55.29M | $1.09M | $12.20M | $245.7M | $245.0M | $245.7M | $101.4M |
| Common Stock | $366K | $363K | $245K | $189K | $150K | $142K | $106K | $106K | $106K | $105K |
| Retained Earnings | -$2.02B | -$1.97B | -$1.77B | -$1.59B | -$1.49B | -$1.40B | -$1.34B | -$1.47B | -$1.37B | -$1.25B |
| Accumulated Other Comp. Income | $30K | $119K | $31K | -$428K | -$10K | -$6.0K | $84K | -$12K | -$222K | -$195K |
| **Total Stockholders' Equity** | $107.5M | $145.9M | $93.11M | $117.1M | $113.6M | $156.4M | $117.1M | -$26.41M | $68.27M | $167.5M |
| Total Equity | $107.5M | $145.9M | $93.11M | $117.1M | $113.6M | $156.4M | $117.1M | -$26.41M | $68.27M | $157.4M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $44.08M | $40.92M | $38.09M | $34.33M | $49.66M | $21.36M | $62.89M | $66.66M |
| Short-Term Investments | $139.1M | $149.7M | $132.6M | $61.90M | $66.29M | $117.6M | $132.0M | $171.3M |
| **Cash & Short-Term Investments** | $183.2M | $190.6M | $170.7M | $96.23M | $116.0M | $139.0M | $194.8M | $238.0M |
| Accounts Receivable, Net | $1.78M | $1.64M | $11.78M | $2.38M | $2.33M | $2.18M | $47.45M | $3.47M |
| Inventory | $1.21M | $1.20M | $276K | $281K | $158K | $168K | $201K | $231K |
| Other Current Assets | $2.65M | $3.13M | $3.32M | $3.00M | $4.08M | $3.73M | $3.32M | $4.53M |
| **Total Current Assets** | $188.8M | $196.6M | $186.0M | $101.9M | $122.5M | $145.1M | $245.8M | $246.2M |
| Property, Plant & Equipment, Net | $1.56M | $1.65M | $1.75M | $1.86M | $1.98M | $2.13M | $2.31M | $2.48M |
| Goodwill | $44.54M | $44.54M | $44.54M | $44.54M | $44.54M | $44.54M | $44.54M | $44.54M |
| Other Non-Current Assets | $369K | $368K | $368K | $368K | $368K | $368K | $368K | $368K |
| **Total Non-Current Assets** | $53.18M | $53.48M | $82.79M | $83.09M | $83.40M | $80.50M | $51.87M | $52.23M |
| **Total Assets** | $242.0M | $250.1M | $268.8M | $185.0M | $205.9M | $225.6M | $297.7M | $298.4M |
| Accounts Payable | $4.25M | $2.34M | $3.00M | $3.08M | $3.80M | $5.90M | $10.69M | $14.80M |
| Short-Term Debt | $0 | $0 | $0 | $4.59M | -- | -- | $42.06M | $0 |
| Deferred Revenue (Current) | -- | -- | -- | -- | $4.30M | $17.46M | -- | $0 |
| **Total Current Liabilities** | $17.77M | $14.71M | $9.90M | $20.87M | $21.72M | $34.84M | $110.7M | $45.25M |
| Long-Term Debt | $51.89M | $51.44M | $49.68M | $49.41M | $56.51M | $56.11M | $58.64M | $100.3M |
| Other Non-Current Liabilities | $8.51M | $9.39M | $6.38M | $7.17M | $7.54M | $5.20M | $5.30M | $6.92M |
| **Total Non-Current Liabilities** | $60.40M | $60.83M | $56.06M | $56.58M | $64.05M | $61.31M | $63.95M | $107.2M |
| **Total Liabilities** | $78.18M | $75.53M | $65.96M | $77.45M | $85.77M | $96.14M | $174.6M | $152.5M |
| **Total Debt (incl. Leases)** | $59.54M | $59.24M | $57.71M | $62.24M | $64.94M | $61.45M | $106.3M | $106.1M |
| Common Stock | $447K | $447K | $426K | $366K | $366K | $366K | $366K | $363K |
| Retained Earnings | -$2.06B | -$2.05B | -$2.02B | -$2.02B | -$2.00B | -$1.99B | -$1.99B | -$1.97B |
| Accumulated Other Comp. Income | -$317K | -$204K | -$130K | $30K | $29K | -$14K | $25K | $119K |
| **Total Stockholders' Equity** | $163.8M | $174.5M | $202.9M | $107.5M | $120.2M | $129.4M | $123.0M | $145.9M |
| Total Equity | $163.8M | $174.5M | $202.9M | $107.5M | $120.2M | $129.4M | $123.0M | $145.9M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$50.34M | -$200.4M | -$177.1M | -$101.9M | -$87.76M | -$58.57M | $130.1M | -$120.5M | -$123.0M | -$131.4M |
| Depreciation & Amortization | $621K | $534K | $554K | $427K | $292K | $2.93M | $3.65M | $3.68M | $3.40M | $2.06M |
| Stock-Based Compensation | $12.52M | $13.50M | $14.34M | $11.52M | $10.58M | $13.27M | $14.22M | $11.70M | $9.47M | $7.45M |
| Change in Receivables | $1.09M | -$2.46M | -$982K | -$14K | $381K | $53.23M | -$50.61M | -$1.10M | $166K | -$4.08M |
| Change in Inventory | -$50K | $150K | -$381K | $0 | $0 | $345K | $437K | -$2.73M | -$1.95M | $0 |
| **Operating Cash Flow** | -$67.85M | -$178.8M | -$161.9M | -$88.85M | -$87.02M | -$143.0M | $113.8M | -$148.6M | -$185.4M | -$175.6M |
| Capital Expenditure | $0 | -$1.03M | -$470K | -$1.33M | -$1.22M | -$87K | -$70K | -$95K | -$228K | -$231K |
| **Free Cash Flow** | -$67.85M | -$179.8M | -$162.4M | -$90.18M | -$88.24M | -$143.1M | $113.7M | -$148.7M | -$185.6M | -$175.9M |
| Purchases of Investments | -$139.8M | -$328.7M | -$223.3M | -$133.9M | -$34.26M | -$58.55M | -$322.4M | -$120.0M | -$267.9M | -$425.7M |
| Sales & Maturities of Investments | $252.9M | $314.4M | $173.9M | $64.20M | $37.59M | $268.0M | $166.6M | $289.7M | $318.6M | $444.2M |
| **Investing Cash Flow** | $113.0M | -$15.38M | -$49.94M | -$71.08M | $2.11M | $380.8M | -$155.9M | $169.6M | $50.52M | $18.25M |
| Common Stock Issued | $0 | $0 | $138.8M | $94.20M | $37.08M | $69.97M | $0 | $732K | $7.99M | $3.62M |
| Share Repurchases | -- | -$1.73M | -$824K | -$864K | -$2.67M | -$1.03M | -$941K | -$972K | -$1.68M | -$621K |
| **Financing Cash Flow** | -$48.50M | $238.3M | $188.0M | $142.2M | $22.71M | -$147.6M | -$2.23M | -$2.24M | $149.9M | $987K |
| **Net Change in Cash** | -$3.33M | $44.19M | -$23.88M | -$17.72M | -$62.20M | $90.15M | -$44.27M | $18.73M | $15.06M | -$156.4M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$14.01M | -$31.77M | -$1.04M | -$15.53M | -$12.77M | $3.25M | -$25.30M | -$33.77M |
| Depreciation & Amortization | $95K | $102K | $110K | $118K | $151K | $176K | $176K | $125K |
| Stock-Based Compensation | $3.38M | $3.34M | $3.08M | $2.83M | $3.44M | $3.19M | $3.04M | $1.54M |
| Change in Receivables | -$134K | $10.14M | -$9.39M | -$50K | -$151K | $264K | $1.03M | -$578K |
| Change in Inventory | -$10K | -$920K | $5.0K | -$123K | $10K | $33K | $30K | $405K |
| **Operating Cash Flow** | -$8.08M | -$9.19M | -$14.73M | -$17.23M | -$23.83M | $16.99M | -$43.78M | -$21.49M |
| Capital Expenditure | -- | -- | -- | -- | -- | -- | -- | -$474K |
| **Free Cash Flow** | -- | -- | -- | -- | -- | -- | -- | -$21.96M |
| Purchases of Investments | -$23.01M | -$57.26M | -$106.0M | -$22.17M | -$26.73M | -$25.97M | -$64.97M | -$25.83M |
| Sales & Maturities of Investments | $34.20M | $40.80M | $35.70M | $27.00M | $78.85M | $41.45M | $105.6M | $80.00M |
| **Investing Cash Flow** | $11.18M | -$16.46M | -$70.26M | $4.83M | $52.12M | $15.48M | $40.58M | $53.70M |
| Common Stock Issued | $0 | $791K | $69.99M | $0 | $0 | $0 | $0 | $0 |
| Share Repurchases | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Financing Cash Flow** | $55K | -$512K | $88.76M | -$2.93M | $0 | -$45.00M | -$572K | -$104K |
| **Net Change in Cash** | $3.16M | -$26.16M | $3.76M | -$15.33M | $28.29M | -$12.52M | -$3.77M | $32.10M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 99.4% | 98.0% | 92.9% | 100.0% | 100.0% | 92.0% | 99.0% | 96.1% | 97.9% | 100.0% |
| **Operating Margin** | -98.2% | -634.2% | -14265.0% | -72489.2% | -29224.8% | -199.2% | 43.9% | -163.4% | -142.5% | -160.5% |
| **Net Profit Margin** | -101.1% | -644.8% | -14710.9% | -73341.0% | -29449.0% | -244.1% | 40.4% | -190.7% | -134.1% | -165.8% |
| Return on Equity (ROE) | -46.8% | -137.3% | -190.2% | -87.0% | -77.3% | -37.5% | 111.1% | -- | -180.2% | -78.5% |
| Return on Assets (ROA) | -27.2% | -67.2% | -77.2% | -52.5% | -64.1% | -28.7% | 31.2% | -42.4% | -28.2% | -27.6% |
| Current Ratio | 4.88x | 5.44x | 5.60x | 6.08x | 4.02x | 3.37x | 5.17x | 4.72x | 3.05x | 2.17x |
| Quick Ratio | 4.87x | 5.44x | 5.58x | 6.08x | 3.92x | 3.37x | 5.10x | 4.59x | 3.03x | 2.17x |
| Debt to Equity | 0.58x | 0.73x | 1.14x | 0.47x | 0.01x | 0.08x | 2.10x | -- | 3.60x | 0.61x |
| **Revenue Growth (YoY)** | +60.2% | +2481.5% | +766.2% | -53.4% | -98.8% | -92.5% | +409.5% | -31.1% | +15.7% | -39.0% |
| Gross Profit Growth (YoY) | +62.6% | +2622.5% | +705.0% | -53.4% | -98.6% | -93.1% | +425.1% | -32.4% | +13.3% | -39.0% |
| Operating Income Growth (YoY) | -- | -- | -- | -- | -- | -133.8% | -- | -- | -- | -8762.9% |
| **Net Income Growth (YoY)** | -- | -- | -- | -- | -- | -145.0% | -- | -- | -- | -- |
| EPS Growth (YoY) | -- | -- | -- | -- | -- | -143.1% | -- | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -- | -- | -225.6% | -- | -- | -- | -195.0% |
| Free Cash Flow Growth (YoY) | -- | -- | -- | -- | -- | -225.8% | -- | -- | -- | -195.6% |
| 5Y Revenue / Share Growth | -- | -- | -99.1% | -99.9% | -99.7% | -- | -- | +1870.3% | +39079.3% | +13963.2% |
| 10Y Revenue / Share Growth | -89.1% | -67.6% | -82.0% | -62.3% | -62.3% | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 98.9% | 99.1% | 99.5% | 99.4% | 99.4% | 99.2% | 98.0% | 98.0% |
| **Operating Margin** | -147.4% | -131.4% | -34.8% | -98.2% | -94.4% | -202.6% | -568.6% | -634.2% |
| **Net Profit Margin** | -161.8% | -147.4% | -37.5% | -101.1% | -96.8% | -206.4% | -568.0% | -644.8% |
| Return on Equity (ROE) | -38.1% | -35.0% | -12.9% | -46.8% | -57.1% | -93.2% | -144.1% | -137.3% |
| Return on Assets (ROA) | -25.8% | -24.4% | -9.7% | -27.2% | -33.3% | -53.5% | -59.6% | -67.2% |
| Current Ratio | 10.63x | 13.37x | 18.79x | 4.88x | 5.64x | 4.16x | 2.22x | 5.44x |
| Quick Ratio | 10.56x | 13.29x | 18.77x | 4.87x | 5.63x | 4.16x | 2.22x | 5.44x |
| Debt to Equity | 0.36x | 0.34x | 0.28x | 0.58x | 0.54x | 0.47x | 0.86x | 0.73x |
| **Revenue Growth (YoY)** | -20.7% | -97.6% | +1572.1% | -79.3% | +710.4% | +1652.6% | +11.7% | +3682.6% |
| Gross Profit Growth (YoY) | -21.2% | -97.7% | +1604.1% | -79.8% | +744.1% | +1846.9% | +12.1% | +4046.5% |
| Operating Income Growth (YoY) | -- | -810.4% | -- | -- | -- | -- | -- | -- |
| **Net Income Growth (YoY)** | -- | -1077.1% | -- | -- | -- | -- | -- | -- |
| EPS Growth (YoY) | -- | -800.0% | -- | -- | -- | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -154.1% | -- | -- | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
